Page last updated: 2024-10-27

guanidinoethylmercaptosuccinic acid and Brain Neoplasms

guanidinoethylmercaptosuccinic acid has been researched along with Brain Neoplasms in 1 studies

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Höring, E1
Harter, PN1
Seznec, J1
Schittenhelm, J1
Bühring, HJ1
Bhattacharyya, S1
von Hattingen, E1
Zachskorn, C1
Mittelbronn, M1
Naumann, U1

Other Studies

1 other study available for guanidinoethylmercaptosuccinic acid and Brain Neoplasms

ArticleYear
The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
    Acta neuropathologica, 2012, Volume: 124, Issue:1

    Topics: Animals; Brain Neoplasms; Carbocyanines; Carboxypeptidase H; Cell Adhesion; Cell Hypoxia; Cell Line,

2012